BOSTON SCIENTIFIC CORPORATION Loss Contingency, Estimate of Possible Loss
BOSTON SCIENTIFIC CORPORATION (BSX) had Loss Contingency, Estimate of Possible Loss of $5.50 billion as of 2015-06-30, per its 10-Q filed 2015-11-04.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2015-11-04
- 2015-06-30: Loss Contingency, Estimate of Possible Loss $5.50B.
- 2015-03-31: Loss Contingency, Estimate of Possible Loss $5.50B.
- 2014-09-30: Loss Contingency, Estimate of Possible Loss $5.50B.
- 2014-06-30: Loss Contingency, Estimate of Possible Loss $5.50B.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2015-06-30 | $5.50B 10-Q · filed 2015-11-04 |
| 2015-03-31 | $5.50B 10-Q · filed 2015-05-06 |
| 2014-09-30 | $5.50B 10-Q · filed 2014-11-05 |
| 2014-06-30 | $5.50B 10-Q · filed 2014-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |